Response to Glucose Deficiency with Sodium-Glucose Cotransporter 2 Inhibitors makes a Positive Impact on Heart and Kidney. Cardiology and Cardiovascular Medicine, v. 6, n. 1, p. 13–18, 26 Jan.2022.